Researchers have identified a protein kinase that controls weight and homeostasis and when deficient or inactivated can lead to metabolic diseases like obesity and type 2 diabetes, according to a mouse study recently published in Endocrinology. Researchers led by Eiichi Hinoi of the Laboratory of Pharmacology in the Department of Bioactive Molecules at Gifu Pharmaceutical...
Measuring waistline, blood pressure, cholesterol, blood fats, and blood sugar during doctor visits can detect heart disease and diabetes earlier, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Primary Prevention of CVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline,” was published online and...
The advent of newer — often very expensive — drugs has driven up the cost of care for diabetes. But older, less expensive medications can often still get the job done. Treating diabetes with lower-cost drugs might not only help a patient’s pocketbook, they might benefit the patient’s health as well. That will be one...
Older patients with diabetes can benefit from even more carefully personalized treatment than their younger counterparts. A new Endocrine Society clinical practice guideline provides a new look at how to care for this growing population. A new Endocrine Society clinical practice guideline aimed at treating diabetes patients 65 years and older stresses that longer life...
Antidepressants reduce deaths by more than a third in patients with diabetes and depression, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. People with diabetes are two to three times more likely to have depression than people without diabetes, according to the U.S. Centers for Disease Control and...
Every ENDO is packed with exciting, groundbreaking science, and of course, one of the highlights each year is the Presidential Plenary. To officially open the proceedings of ENDO 2019 in New Orleans, attendees were fortunate to have Francis S. Collins, MD, PhD, the director of the National Institutes of Health, deliver the Presidential Plenary speech,...
Low blood sugar at time of discharge increases risk of death Patients with diabetes and low blood glucose have higher rates of death following hospital discharge, according to a study published in The Journal of Clinical Endocrinology & Metabolism. The cost for hospital readmissions within 30 days of discharge is estimated to be close to $25...
Individuals who take statins may be at higher risk for developing high blood sugar levels, insulin resistance, and eventually type 2 diabetes, according to an analysis published in the British Journal of Clinical Pharmacology. Researchers led by Prof. Bruno Stricker, of the Erasmus Medical Centre, in the Netherlands point out that while there are several epidemiological...
The advent of newer — often very expensive — drugs has driven up the cost of care for diabetes. But older, less expensive medications can often still get the job done. Treating diabetes with lower-cost drugs might not only help a patient’s pocketbook, they might benefit the patient’s health as well. That will be one...
Every ENDO is packed with exciting, groundbreaking science, and of course, one of the highlights each year is the Presidential Plenary. To officially open the proceedings of ENDO 2019 in New Orleans, attendees were fortunate to have Francis S. Collins, MD, PhD, the director of the National Institutes of Health, deliver the Presidential Plenary speech,...
